Provexis plc (AIM:PXS)
London · Delayed Price · Currency is GBP · Price in GBX 0.6250
0.00 (0.00%)
At close: Dec 5, 2025
Provexis Market Cap
Provexis has a market cap or net worth of 14.66 million as of December 5, 2025. Its market cap has increased by 13.27% in one year.
Market Cap
14.66M
Enterprise Value
13.42M
Revenue
1.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.63
Market Cap Chart
Since September 7, 2005, Provexis's market cap has increased from 2.24M to 14.66M, an increase of 553.89%. That is a compound annual growth rate of 9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 14.66M | -7.41% |
| Dec 31, 2024 | 15.83M | 9.84% |
| Dec 29, 2023 | 14.42M | -10.34% |
| Dec 30, 2022 | 16.08M | -6.76% |
| Dec 31, 2021 | 17.24M | -2.21% |
| Dec 31, 2020 | 17.63M | 30.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.00B |
| GSK plc | 73.57B |
| Haleon | 32.16B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |